Deep Genomics' AI Platform Helped Discover New Wilson Disease Drug Candidate
Executive Summary
The startup's artificial intelligence-based platform helped the company identify its first drug candidate in one-fifth the usual timespan, CEO Brendan Frey said.
You may also be interested in...
Life Sciences Under The Microscope – Machine Learning
The life sciences industry is undergoing a challenging period. Although artificial intelligence and machine learning are quickly being adopted to enhance business operations and provide extra value and insights, the necessary data science talent is worryingly scarce. David Bennett, life sciences advisor at Mind Foundry, explains how the latest accessible machine learning platforms will be key in assisting R&D and commercial departments realize the true value of their data.
VBI Is Ready To Take On HBV Vaccine Market
VBI’s Sci-B-Vac CONSTANT data firmly establishes the hepatitis B vaccine’s advantages over GSK’s longstanding Engerix-B, but it faces a tougher challenge with Heplisav-B from Dynavax.
Apellis Comes Closer To Taking On Alexion In PNH
Besting Alexion’s Soliris in a head-to-head Phase III trial portends a place in the market for Apellis’ competitor in paroxysmal nocturnal hemoglobinuria. But challenges dog both companies.